Niagen Bioscience, Inc. (NAGE) Earnings
|
Expand Research on NAGE
| Next EPS Date | 11/4/26 | EPS Growth Rate | -60.0% |
|---|---|---|---|
| Average EPS % Beat Rate | +59.4% | Revenue Growth Rate | +1.3% |
| Average % Move 1-Wk after EPS | -8.8% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/4/26  |
Q326 | N/A | $0.02 | N/A | N/A | $34.44M | N/A | N/A | N/A | ||
| 8/4/26 |
Q226 | $0.01 | $0.02 | -$0.01 | $29.8M | $32.18M | N/A |  | | Details | |
| 5/6/26 | Q126 | $0.07 | $0.08 | -$0.01 | $31.5M | $30.23M | N/A | | | Details | |
| 3/4/26 | Q425 | $0.05 | $0.02 | +$0.03 | $33.8M | $31.7M | N/A | | | Details | |
| 11/4/25 | Q325 | $0.05 | $0.02 | +$0.03 | $34M | $30.83M | N/A | | | Details | |
| 8/6/25 | Q225 | $0.04 | $0.02 | +$0.02 | $31.1M | $28.36M | N/A | | | Details | |
| 5/7/25 | Q125 | $0.06 | $0.02 | +$0.04 | $30.5M | $27.07M | N/A | | | Details |
